Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Meurer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body|January 29, 2021
The end of the 'Bad seed' Era? Epigenetics' contribution to violence prevention initiatives in public healthAnna Meurer
Scientific Reports|July 21, 2022
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cellsChristina Martins, Mariana Silva, Erik Rasbach, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2026
Aberrant SUMOylation Restricts the Targetable Cancer ImmunopeptidomeUta M Demel, Anna Meurer, Badeel Kh Q Zaghla, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
A prospective observational study of real-world treatment and outcome in secondary CNS lymphomaStefan Habringer, Uta M Demel, Anne-Katrin Fietz, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body|January 29, 2021
The end of the 'Bad seed' Era? Epigenetics' contribution to violence prevention initiatives in public healthAnna Meurer
Scientific Reports|July 21, 2022
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cellsChristina Martins, Mariana Silva, Erik Rasbach, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2026
Aberrant SUMOylation Restricts the Targetable Cancer ImmunopeptidomeUta M Demel, Anna Meurer, Badeel Kh Q Zaghla, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
A prospective observational study of real-world treatment and outcome in secondary CNS lymphomaStefan Habringer, Uta M Demel, Anne-Katrin Fietz, et al.
Pageof 1